GSK-JPM-20240109.pdf

1、9 January 20249 January 2024Delivering strong and sustained momentumDelivering strong and sustained momentumEmma Walmsley,Chief Executive OfficerJ.P.Morgan Healthcare Conference,San Francisco2This presentation may contain forward-looking statements.Forward-looking statements give the Groups current

2、expectations or forecasts of future events.An investor can identify thesestatements by the fact that they do not relate strictly to historical or current facts.They use words such as anticipate,estimate,expect,intend,will,project,plan,believe,target andother words and terms of similar meaning in con

3、nection with any discussion of future operating or financial performance.In particular,these include statements relating to future actions,prospective products or product approvals,future performance or results of current and anticipated products,sales efforts,expenses,the outcome of contingencies s

4、uch as legalproceedings,dividend payments and financial results.Other than in accordance with its legal or regulatory obligations(including under the Market Abuse Regulations,UK Listing Rules and the Disclosure Guidance and Transparency Rules ofthe Financial Conduct Authority),the Group undertakes n

5、o obligation to update any forward-looking statements,whether as a result of new information,future events or otherwise.Investors should,however,consult any additional disclosures that the Group may make in any documents which it publishes and/or files with the US Securities and Exchange Commission(

6、SEC).All investors,wherever located,should take note of these disclosures.Accordingly,no assurance can be given that any particular expectation will be met and investors arecautioned not to place undue reliance on the forward-looking statements.Forward-looking statements are subject to assumptions,i